These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9236850)

  • 1. First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studies.
    Monia BP
    Anticancer Drug Des; 1997 Jul; 12(5):327-39. PubMed ID: 9236850
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicological and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC-alpha and C-raf kinase.
    Henry SP; Monteith D; Bennett F; Levin AA
    Anticancer Drug Des; 1997 Jul; 12(5):409-20. PubMed ID: 9236856
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
    Soldatenkov VA; Dritschilo A; Wang FH; Olah Z; Anderson WB; Kasid U
    Cancer J Sci Am; 1997; 3(1):13-20. PubMed ID: 9072302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAF antisense oligonucleotide as a tumor radiosensitizer.
    Kasid U; Dritschilo A
    Oncogene; 2003 Sep; 22(37):5876-84. PubMed ID: 12947394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors.
    Altmann KH; Fabbro D; Dean NM; Geiger T; Monia BP; Müller M; Nicklin P
    Biochem Soc Trans; 1996 Aug; 24(3):630-7. PubMed ID: 8878817
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.
    Monia BP; Sasmor H; Johnston JF; Freier SM; Lesnik EA; Muller M; Geiger T; Altmann KH; Moser H; Fabbro D
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15481-4. PubMed ID: 8986837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS; Cho-Chung YS
    Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
    Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents.
    Dean NM; McKay R; Miraglia L; Geiger T; Müller M; Fabbro D; Bennett CF
    Biochem Soc Trans; 1996 Aug; 24(3):623-9. PubMed ID: 8878816
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
    Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
    J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER.
    McCarthy SA; Aziz N; McMahon M
    Methods Mol Biol; 1997; 85():137-51. PubMed ID: 9276321
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells.
    Mewani RR; Tian S; Li B; Danner MT; Carr TD; Lee S; Rahman A; Kasid UN; Jung M; Dritschilo A; Gokhale PC
    Int J Mol Med; 2006 Mar; 17(3):457-63. PubMed ID: 16465392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of antisense oligonucleotide efficacy by in vitro methods.
    Matveeva O; Felden B; Tsodikov A; Johnston J; Monia BP; Atkins JF; Gesteland RF; Freier SM
    Nat Biotechnol; 1998 Dec; 16(13):1374-5. PubMed ID: 9853623
    [No Abstract]   [Full Text] [Related]  

  • 14. 2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotides.
    Griffey RH; Monia BP; Cummins LL; Freier S; Greig MJ; Guinosso CJ; Lesnik E; Manalili SM; Mohan V; Owens S; Ross BR; Sasmor H; Wancewicz E; Weiler K; Wheeler PD; Cook PD
    J Med Chem; 1996 Dec; 39(26):5100-9. PubMed ID: 8978841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinase.
    Monia BP
    Ciba Found Symp; 1997; 209():107-19; discussion 119-23. PubMed ID: 9383572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of C-raf antisense--correction.
    Monia BP
    Nat Med; 1999 Feb; 5(2):127. PubMed ID: 9930845
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.
    Khatib AM; Fallavollita L; Wancewicz EV; Monia BP; Brodt P
    Cancer Res; 2002 Oct; 62(19):5393-8. PubMed ID: 12359742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective gene therapy for proliferative disorders: sense and antisense.
    Indolfi C; Chiariello M; Avvedimento EV
    Nat Med; 1996 Jun; 2(6):634-5. PubMed ID: 8640548
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and cellular characterization of baboon C-Raf as a target for antiproliferative effects of antisense oligonucleotides.
    Mandiyan S; Schumacher C; Cioffi C; Sharif H; Yuryev A; Lappe R; Monia B; Hanson S; Goff S; Wennogle L
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):539-48. PubMed ID: 9450911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.